{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:58:18Z","timestamp":1793825898423,"version":"4.6.1"},"reference-count":250,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008546","name":"Diabetesf\u00f6rbundet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008546","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","award":["11 CVD 03"],"award-info":[{"award-number":["11 CVD 03"]}],"id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005754","name":"Sahlgrenska Universitetssjukhuset","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005754","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.atherosclerosis.2015.01.039","type":"journal-article","created":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T09:18:47Z","timestamp":1423300727000},"page":"483-495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":385,"title":["New insights into the pathophysiology of dyslipidemia in type 2 diabetes"],"prefix":"10.1016","volume":"239","author":[{"given":"Marja-Riitta","family":"Taskinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bor\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2213-8587(13)70112-8","article-title":"Diabetes: a 21st century challenge","volume":"2","author":"Zimmet","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/MED.0000000000000044","article-title":"Type 2 diabetes and cardiovascular disease: what next?","volume":"21","author":"Joseph","year":"2014","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Emerging Risk Factors Collaboration","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib7","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990\u20132010","volume":"370","author":"Gregg","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib8","doi-asserted-by":"crossref","first-page":"E642","DOI":"10.1210\/jc.2013-3210","article-title":"Improved survival among patients with complicated type 2 diabetes in Denmark: a prospective study (2002\u20132010)","volume":"99","author":"Faerch","year":"2014","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib9","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Emerging Risk Factors Collaboration","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib10","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s00125-012-2817-5","article-title":"Revisiting the links between glycaemia, diabetes and cardiovascular disease","volume":"56","author":"Sattar","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2796.1998.00368.x","article-title":"Coronary heart disease mortality amongst non-insulin-dependent diabetic subjects in Iceland: the independent effect of diabetes. The Reykjavik Study 17-year follow up","volume":"244","author":"Vilbergsson","year":"1998","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabettic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib13","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"Group","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/1566524053766086","article-title":"Type 2 diabetes as a lipid disorder","volume":"5","author":"Taskinen","year":"2005","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib16","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/diacare.24.4.683","article-title":"Cardiovascular morbidity and mortality associated with the metabolic syndrome","volume":"24","author":"Isomaa","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1475-2840-10-102","article-title":"Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial","volume":"10","author":"Scott","year":"2011","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/HJR.0b013e32833ba61e","article-title":"Blood lipids in 75,048 type 2 diabetic patients: a population-based survey from the Swedish National Diabetes Register","volume":"18","author":"Eriksson","year":"2011","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil. Off. J. Eur. Soc. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib20","first-page":"11","article-title":"Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus","volume":"6","author":"Feher","year":"2013","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib21","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1464-5491.2011.03360.x","article-title":"Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study","volume":"28","author":"Leiter","year":"2011","journal-title":"Diabet. Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.atherosclerosis.2013.09.020","article-title":"Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: findings from the EUROASPIRE III survey","volume":"231","author":"Reiner","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2796.2005.01556.x","article-title":"Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis","volume":"258","author":"Olofsson","year":"2005","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1194\/jlr.M200413-JLR200","article-title":"Immunochemical evidence that human apoB differs when expressed in rodent versus human cells","volume":"44","author":"Wang","year":"2003","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-2275(20)34206-1","article-title":"Apolipoprotein B-100: conservation of lipid-associating amphipathic secondary structural motifs in nine species of vertebrates","volume":"39","author":"Segrest","year":"1998","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/MOL.0000000000000084","article-title":"Intestinal lipid absorption and lipoprotein formation","volume":"25","author":"Hussain","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.biochi.2013.07.009","article-title":"Triglyceride-rich lipoproteins and cytosolic lipid droplets in enterocytes: key players in intestinal physiology and metabolic disorders","volume":"96","author":"Demignot","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib28","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbalip.2012.01.006","article-title":"Postprandial metabolism of meal triglyceride in humans","volume":"1821","author":"Lambert","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib29","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1194\/jlr.M500023-JLR200","article-title":"Evidence for multiple complementary pathways for efficient cholesterol absorption in mice","volume":"46","author":"Iqbal","year":"2005","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib30","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00125-005-1753-z","article-title":"Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes","volume":"48","author":"Hiukka","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib31","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1172\/JCI107334","article-title":"Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man","volume":"52","author":"Brunzell","year":"1973","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.atherosclerosis.2012.02.001","article-title":"Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity","volume":"222","author":"Adiels","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/joim.12071","article-title":"Ectopic lipid storage and insulin resistance: a harmful relationship","volume":"274","author":"Boren","year":"2013","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib34","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/ATVBAHA.112.251116","article-title":"Apolipoprotein B secretory regulation by degradation","volume":"32","author":"Olofsson","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib35","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1152\/physrev.00019.2011","article-title":"Role of the gut in lipid homeostasis","volume":"92","author":"Abumrad","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib36","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.bbalip.2011.09.019","article-title":"Regulation of chylomicron production in humans","volume":"1821","author":"Xiao","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib37","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/ATVBAHA.113.302993","article-title":"Intestinal lipid handling: evidence and implication of insulin signaling abnormalities in human obese subjects","volume":"34","author":"Veilleux","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib38","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.atherosclerosis.2013.12.047","article-title":"New and emerging regulators of intestinal lipoprotein secretion","volume":"233","author":"Xiao","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib39","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/S0022-2275(20)35345-1","article-title":"Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters","volume":"34","author":"Cohn","year":"1993","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1161\/01.ATV.15.2.199","article-title":"Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100","volume":"15","author":"Karpe","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib41","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1161\/ATVBAHA.112.246207","article-title":"Exenatide, a glucagon-like peptide-1 receptor agonist, acutely inhibits intestinal lipoprotein production in healthy humans","volume":"32","author":"Xiao","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib42","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.08.037","article-title":"Glucagon-like peptide-2 regulates release of chylomicrons from the intestine","volume":"147","author":"Dash","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib43","first-page":"A76","article-title":"Glucagon-like peptide-2 acutely stimulates chylomicron release in healthy humans","volume":"62","author":"Dash","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib44","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/ATVBAHA.112.300769","article-title":"Novel role of enteral monosaccharides in intestinal lipoprotein production in healthy humans","volume":"33","author":"Xiao","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib45","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1161\/ATVBAHA.113.302342","article-title":"High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight\/obese men","volume":"33","author":"Dash","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib46","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1194\/jlr.P800061-JLR200","article-title":"Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia","volume":"50","author":"Tremblay","year":"2009","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib47","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/gut.2008.165886","article-title":"Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability","volume":"58","author":"Cani","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib48","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00125-005-0125-z","article-title":"Overproduction of large VLDL particles is driven by increased liver fat content in man","volume":"49","author":"Adiels","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.atherosclerosis.2010.01.028","article-title":"Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes","volume":"211","author":"Verges","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20121689","article-title":"Hepatic triacylglycerol synthesis and secretion: DGAT2 as the link between glycaemia and triglyceridaemia","volume":"451","author":"Zammit","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib51","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature13478","article-title":"The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes","volume":"510","author":"Perry","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib52","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tem.2012.09.005","article-title":"Dissociating fatty liver and diabetes","volume":"24","author":"Sun","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib53","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1161\/ATVBAHA.111.224808","article-title":"Dual metabolic defects are required to produce hypertriglyceridemia in obese subjects","volume":"31","author":"Taskinen","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib54","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2796.2011.02497.x","article-title":"Kinetic studies to investigate lipoprotein metabolism","volume":"271","author":"Boren","year":"2012","journal-title":"J.\u00a0Intern Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib55","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1007\/s00125-007-0790-1","article-title":"Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance","volume":"50","author":"Adiels","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib56","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11892-008-0011-4","article-title":"Fatty liver, insulin resistance, and dyslipidemia","volume":"8","author":"Adiels","year":"2008","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib57","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/ATVBAHA.111.241463","article-title":"Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia","volume":"32","author":"Sparks","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib58","first-page":"178","article-title":"Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion","volume":"28","author":"Fisher","year":"2014","journal-title":"J.\u00a0Biomed. Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib59","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.tem.2013.04.001","article-title":"The regulation of ApoB metabolism by insulin","volume":"24","author":"Haas","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib60","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00125-013-2869-1","article-title":"Insulin signalling mechanisms for triacylglycerol storage","volume":"56","author":"Czech","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib61","doi-asserted-by":"crossref","first-page":"20462","DOI":"10.1074\/jbc.R114.576355","article-title":"Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux","volume":"289","author":"Otero","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib62","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1172\/JCI117633","article-title":"Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans","volume":"95","author":"Lewis","year":"1995","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib63","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.2337\/diabetes.54.9.2694","article-title":"Increased dietary substrate delivery alters hepatic fatty acid recycling in healthy men","volume":"54","author":"Timlin","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib64","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MOL.0b013e3283544956","article-title":"Determinants of VLDL-triglycerides production","volume":"23","author":"Nielsen","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib65","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/physrev.00033.2011","article-title":"Pathophysiology of human visceral obesity: an update","volume":"93","author":"Tchernof","year":"2013","journal-title":"Physiol. Rev."},{"issue":"Pt 1","key":"10.1016\/j.atherosclerosis.2015.01.039_bib66","first-page":"1","article-title":"Role of insulin in hepatic fatty acid partitioning: emerging concepts","volume":"314","author":"Zammit","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib67","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MOL.0b013e3283462e16","article-title":"Hepatic fatty acid partitioning","volume":"22","author":"Hodson","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib68","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1172\/JCI106422","article-title":"Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans","volume":"49","author":"Havel","year":"1970","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib69","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1172\/JCI21047","article-title":"Splanchnic lipolysis in human obesity","volume":"113","author":"Nielsen","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib70","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1194\/jlr.R600011-JLR200","article-title":"Thematic review series: patient-oriented research. Free fatty acid metabolism in human obesity","volume":"47","author":"Koutsari","year":"2006","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib71","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/j.2040-4603.2014.tb00548.x","article-title":"Energy metabolism in the liver","volume":"4","author":"Rui","year":"2014","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib72","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib73","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.trsl.2014.06.008","article-title":"Obesity and the liver: nonalcoholic fatty liver disease","volume":"164","author":"Koppe","year":"2014","journal-title":"Transl. Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib74","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrgastro.2014.232","article-title":"NAFLD in 2014: genetics, diagnostics and therapeutic advances in NAFLD","volume":"2","author":"Rinella","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib75","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrgastro.2013.182","article-title":"The genetics of NAFLD","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib76","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib77","doi-asserted-by":"crossref","first-page":"e1001324","DOI":"10.1371\/journal.pgen.1001324","article-title":"Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits","volume":"7","author":"Speliotes","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib78","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.amjcard.2004.02.058","article-title":"The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health","volume":"93","author":"Victor","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib79","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib80","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cmet.2012.04.008","article-title":"Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase","volume":"15","author":"Kumari","year":"2012","journal-title":"Cell. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib81","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1194\/jlr.M011205","article-title":"Pnpla3\/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome","volume":"52","author":"Basantani","year":"2011","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib82","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.27242","article-title":"Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis","volume":"61","author":"Smagris","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib83","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jhep.2012.07.030","article-title":"Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in\u00a0vitro","volume":"57","author":"Pirazzi","year":"2012","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib84","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1056\/NEJMoa0907295","article-title":"Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease","volume":"362","author":"Petersen","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib85","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/hep.24072","article-title":"Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance","volume":"53","author":"Kozlitina","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib86","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.jhep.2011.03.035","article-title":"The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver","volume":"55","author":"Valenti","year":"2011","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib87","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1476-511X-10-93","article-title":"Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans","volume":"10","author":"Sentinelli","year":"2011","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib88","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/ijo.2011.154","article-title":"Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content","volume":"36","author":"Peter","year":"2012","journal-title":"Int. J. Obes. Lond"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib89","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1194\/jlr.M600200-JLR200","article-title":"Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans","volume":"47","author":"Vedala","year":"2006","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib90","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1262-3636(07)70061-7","article-title":"Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease","volume":"29","author":"Diraison","year":"2003","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib91","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ajcn\/77.1.43","article-title":"Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets","volume":"77","author":"Schwarz","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib92","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1007\/s00125-009-1405-9","article-title":"Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes","volume":"52","author":"Wilke","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib93","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/ajcn\/73.2.253","article-title":"Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men","volume":"73","author":"Marques-Lopes","year":"2001","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib94","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.26672","article-title":"Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes","volume":"59","author":"Birkenfeld","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib95","first-page":"221","article-title":"Molecular pathways in non-alcoholic fatty liver disease","volume":"7","author":"Berlanga","year":"2014","journal-title":"Clin. Exp. Gastroenterol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib96","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-0033-1358523","article-title":"Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP","volume":"33","author":"Xu","year":"2013","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib97","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbalip.2014.05.001","article-title":"Transcription factor networks regulating hepatic fatty acid metabolism","volume":"1851","author":"Karagianni","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.atherosclerosis.2015.01.039_bib98","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1463-1326.2010.01275.x","article-title":"Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c","volume":"12","author":"Ferre","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tem.2010.09.002","article-title":"Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter","volume":"22","author":"Lodhi","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib100","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI34275","article-title":"Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice","volume":"118","author":"Postic","year":"2008","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib101","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.bbalip.2011.09.017","article-title":"Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger?","volume":"1821","author":"Jensen-Urstad","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib102","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1194\/jlr.M700600-JLR200","article-title":"Compartmentalization of stearoyl-coenzyme A desaturase 1 activity in HepG2 cells","volume":"49","author":"Yee","year":"2008","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib103","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3945\/ajcn.110.006502","article-title":"Adipose tissue palmitoleic acid and obesity in humans: does it behave as a lipokine?","volume":"93","author":"Gong","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib104","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.plipres.2012.08.002","article-title":"Stearoyl-CoA desaturase: rogue or innocent bystander?","volume":"52","author":"Hodson","year":"2013","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3945\/ajcn.114.092262","article-title":"Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis","volume":"101","author":"Lee","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib106","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S0022-2275(20)32553-0","article-title":"Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men","volume":"39","author":"Aarsland","year":"1998","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib107","doi-asserted-by":"crossref","first-page":"11143","DOI":"10.1016\/S0021-9258(19)38569-2","article-title":"Diet fat composition alters membrane phospholipid composition, insulin binding, and glucose metabolism in adipocytes from control and diabetic animals","volume":"265","author":"Field","year":"1990","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib108","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2008.07.048","article-title":"Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism","volume":"134","author":"Cao","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib109","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1749-6632.2011.06303.x","article-title":"The role of stearoyl-CoA desaturase in obesity, insulin resistance, and inflammation","volume":"1243","author":"Sampath","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/MOL.0b013e32834d2dc5","article-title":"Recent insights into the relation of Delta5 desaturase and Delta6 desaturase activity to the development of type 2 diabetes","volume":"23","author":"Kroger","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib111","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2337\/db08-1074","article-title":"Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver","volume":"58","author":"Kotronen","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib112","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s00125-008-0938-7","article-title":"Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans","volume":"51","author":"Stefan","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib113","doi-asserted-by":"crossref","first-page":"E2288","DOI":"10.1210\/jc.2012-2152","article-title":"High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet","volume":"97","author":"Silbernagel","year":"2012","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib114","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib115","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/oby.20781","article-title":"Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride-rich lipoproteins","volume":"22","author":"Matikainen","year":"2014","journal-title":"Obesity Silver Spring"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib116","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.metabol.2014.04.003","article-title":"De novo lipogenesis in health and disease","volume":"63","author":"Ameer","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib117","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3945\/an.113.004648","article-title":"Hepatic fatty acid trafficking: multiple forks in the road","volume":"4","author":"Mashek","year":"2013","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib118","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/0026-0495(93)90232-D","article-title":"Low-density lipoprotein metabolism in rats treated with cyclosporine","volume":"42","author":"Lopez-Miranda","year":"1993","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib119","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.2337\/db11-0231","article-title":"The metabolically benign and malignant fatty liver","volume":"60","author":"Stefan","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib120","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.bbadis.2014.08.004","article-title":"Nonalcoholic fatty liver disease: a main driver of insulin resistance or a dangerous liaison?","volume":"1842","author":"Gruben","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib121","doi-asserted-by":"crossref","first-page":"28237","DOI":"10.1074\/jbc.M114.571190","article-title":"Diacylglycerol acyltransferase-2 (DGAT2) and monoacylglycerol acyltransferase-2 (MGAT2) interact to promote triacylglycerol synthesis","volume":"289","author":"Jin","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib122","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2012.04.005","article-title":"Role of ceramides in nonalcoholic fatty liver disease","volume":"23","author":"Pagadala","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib123","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.03.003","article-title":"Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects","volume":"142","author":"Magkos","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib124","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1074\/jbc.271.5.2353","article-title":"Biosynthesis of apolipoprotein B48-containing lipoproteins. Regulation by novel post-transcriptional mechanisms","volume":"271","author":"Innerarity","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib125","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/ATVBAHA.107.160192","article-title":"Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome","volume":"28","author":"Adiels","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib126","doi-asserted-by":"crossref","first-page":"9858","DOI":"10.1016\/S0021-9258(19)50173-9","article-title":"The assembly and secretion of ApoB 100-containing lipoproteins in Hep G2 cells. ApoB 100 is cotranslationally integrated into lipoproteins","volume":"267","author":"Boren","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib127","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0009-3084(85)90068-4","article-title":"Purification and characterization of microsomal triglyceride and cholesteryl ester transfer protein from bovine liver microsomes","volume":"38","author":"Wetterau","year":"1985","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib128","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1139\/O09-168","article-title":"Apolipoprotein B100 biogenesis: a complex array of intracellular mechanisms regulating folding, stability, and lipoprotein assembly","volume":"88","author":"Rutledge","year":"2010","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib129","first-page":"491","article-title":"Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease","volume":"3","author":"Olofsson","year":"2007","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib130","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1194\/jlr.M400296-JLR200","article-title":"Relation of the size and intracellular sorting of apoB to the formation of VLDL 1 and VLDL 2","volume":"46","author":"Stillemark-Billton","year":"2005","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib131","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MOL.0b013e32835aebe7","article-title":"Microsome-associated lumenal lipid droplets in the regulation of lipoprotein secretion","volume":"24","author":"Yao","year":"2013","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib132","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1515\/cclm-2013-0358","article-title":"Recent advances in physiological lipoprotein metabolism","volume":"52","author":"Ramasamy","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib133","doi-asserted-by":"crossref","first-page":"13800","DOI":"10.1016\/S0021-9258(18)67090-5","article-title":"Pulse-chase studies of the synthesis and intracellular transport of apolipoprotein B-100 in Hep G2 cells","volume":"261","author":"Bostrom","year":"1986","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib134","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/ATVBAHA.112.251116","article-title":"Apolipoprotein B secretory regulation by degradation","volume":"32","author":"Olofsson","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib135","doi-asserted-by":"crossref","first-page":"17377","DOI":"10.1074\/jbc.R100068200","article-title":"Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins","volume":"277","author":"Fisher","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib136","doi-asserted-by":"crossref","first-page":"27855","DOI":"10.1074\/jbc.M008885200","article-title":"The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways","volume":"276","author":"Fisher","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib137","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1172\/JCI19197","article-title":"Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production","volume":"113","author":"Pan","year":"2004","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib138","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.tem.2008.07.002","article-title":"The many intersecting pathways underlying apolipoprotein B secretion and degradation","volume":"19","author":"Brodsky","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib139","doi-asserted-by":"crossref","first-page":"721","DOI":"10.4161\/auto.6346","article-title":"Autophagy of an oxidized, aggregated protein beyond the ER: a pathway for remarkably late-stage quality control","volume":"4","author":"Fisher","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib140","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ki.1993.60","article-title":"Lipoprotein heterogeneity in end-stage renal disease","volume":"43","author":"Joven","year":"1993","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib141","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1042\/bj2840457","article-title":"The lipolysis\/esterification cycle of hepatic triacylglycerol. Its role in the secretion of very-low-density lipoprotein and its response to hormones and sulphonylureas","volume":"284","author":"Wiggins","year":"1992","journal-title":"Biochem. J."},{"issue":"Pt 3","key":"10.1016\/j.atherosclerosis.2015.01.039_bib142","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/bj3320667","article-title":"The intracellular triacylglycerol\/fatty acid cycle: a comparison of its activity in hepatocytes which secrete exclusively apolipoprotein (apo) B100 very-low-density lipoprotein (VLDL) and in those which secrete predominantly apoB48 VLDL","volume":"332","author":"Salter","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib143","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1388-1981(99)00182-1","article-title":"Mobilisation of triacylglycerol stores","volume":"1483","author":"Gibbons","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib144","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1743-7075-7-35","article-title":"Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion","volume":"7","author":"Sundaram","year":"2010","journal-title":"Nutr. Metab. Lond."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(87)90088-8","article-title":"Apolipoprotein B: structure, biosynthesis and role in the lipoprotein assembly process","volume":"68","author":"Olofsson","year":"1987","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib146","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0968-0004(98)01349-8","article-title":"Mechanisms of lipid-body formation","volume":"24","author":"Murphy","year":"1999","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib147","doi-asserted-by":"crossref","first-page":"R446","DOI":"10.1016\/S0960-9822(01)00257-3","article-title":"Lipid droplets: proteins floating on a pool of fat","volume":"11","author":"Brown","year":"2001","journal-title":"Curr. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib148","doi-asserted-by":"crossref","first-page":"27793","DOI":"10.1074\/jbc.274.39.27793","article-title":"The activity of microsomal triglyceride transfer protein is essential for accumulation of triglyceride within microsomes in McA-RH7777 cells. A unified model for the assembly of very low density lipoproteins","volume":"274","author":"Wang","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib149","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/1871529X11202020133","article-title":"Human apolipoprotein C-III \u2013 a new intrahepatic protein factor promoting assembly and secretion of very low density lipoproteins","volume":"12","author":"Yao","year":"2012","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib150","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MOL.0b013e328352dc70","article-title":"Apolipoprotein C-III and hepatic triglyceride-rich lipoprotein production","volume":"23","author":"Yao","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib151","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1194\/jlr.M900346-JLR200","article-title":"Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions","volume":"51","author":"Sundaram","year":"2010","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib152","doi-asserted-by":"crossref","first-page":"27769","DOI":"10.1074\/jbc.M110.203679","volume":"286","author":"Qin","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib153","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1194\/jlr.M005108","article-title":"Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia","volume":"51","author":"Sundaram","year":"2010","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2008.08.001","article-title":"Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)","volume":"48","author":"Musso","year":"2009","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib155","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","article-title":"A\u00a0position statement on NAFLD\/NASH based on the EASL 2009 special conference","volume":"53","author":"Ratziu","year":"2010","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib156","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2337\/diab.31.3.217","article-title":"Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus","volume":"31","author":"Kissebah","year":"1982","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib157","first-page":"685","article-title":"Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study","volume":"30","author":"Duvillard","year":"2000","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib158","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1124\/jpet.103.048991","article-title":"Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes","volume":"306","author":"Ouguerram","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib159","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/BF00400586","article-title":"Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM","volume":"38","author":"Cummings","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib160","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/ATVBAHA.111.244525","article-title":"NOX4 pathway as a source of selective insulin resistance and responsiveness","volume":"32","author":"Wu","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib161","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.yexcr.2014.09.025","article-title":"Selective insulin resistance in hepatocyte senescence","volume":"331","author":"Aravinthan","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib162","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.4161\/cc.7.20.6882","article-title":"FoxO1 integrates insulin signaling to VLDL production","volume":"7","author":"Kamagate","year":"2008","journal-title":"Cell. Cycle"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib163","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cmet.2011.09.001","article-title":"Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c","volume":"14","author":"Wan","year":"2011","journal-title":"Cell. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib164","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3109\/10409238.2011.562481","article-title":"Insulin signaling to hepatic lipid metabolism in health and disease","volume":"46","author":"Leavens","year":"2011","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib165","first-page":"2347","article-title":"FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice","volume":"118","author":"Kamagate","year":"2008","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib166","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1172\/JCI61248","article-title":"Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice","volume":"122","author":"Ai","year":"2012","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib167","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1172\/JCI63563","article-title":"Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism","volume":"122","author":"Strong","year":"2012","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib168","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1242\/jcs.02941","article-title":"PLD1 and ERK2 regulate cytosolic lipid droplet formation","volume":"119","author":"Andersson","year":"2006","journal-title":"J.\u00a0Cell. Sci."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib169","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1161\/01.ATV.0000172689.53992.25","article-title":"Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia","volume":"25","author":"Adiels","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib170","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00125-003-1111-y","article-title":"Diabetic dyslipidaemia: from basic research to clinical practice","volume":"46","author":"Taskinen","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib171","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1161\/01.ATV.17.7.1454","article-title":"Metabolic basis of hypotriglyceridemic effects of insulin in normal men","volume":"17","author":"Malmstrom","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib172","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2337\/diab.42.6.833","article-title":"Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals","volume":"42","author":"Lewis","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib173","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2337\/diab.44.9.1059","article-title":"Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM","volume":"44","author":"Cummings","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib174","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1007\/s00125-012-2624-z","article-title":"Postprandial VLDL-triacylglycerol secretion is not suppressed in obese type 2 diabetic men","volume":"55","author":"Sondergaard","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib175","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1073\/pnas.0904944106","article-title":"Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity","volume":"106","author":"Fabbrini","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib176","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.2337\/db11-0040","article-title":"Increased VLDL-triglyceride secretion precedes impaired control of endogenous glucose production in obese, normoglycemic men","volume":"60","author":"Sorensen","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib177","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.plipres.2014.02.002","article-title":"Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes","volume":"54","author":"Sahini","year":"2014","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib178","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.26226","article-title":"Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease","volume":"58","author":"Begriche","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib179","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1515\/JBCPP.1998.9.2-4.295","article-title":"Malonyl CoA, long chain fatty acyl CoA and insulin resistance in skeletal muscle","volume":"9","author":"Ruderman","year":"1998","journal-title":"J.\u00a0Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib180","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.plefa.2003.09.007","article-title":"The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism","volume":"70","author":"Veech","year":"2004","journal-title":"Prostagl. Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib181","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.plipres.2013.12.001","article-title":"Regulation of energy metabolism by long-chain fatty acids","volume":"53","author":"Nakamura","year":"2014","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib182","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","article-title":"The interaction of hepatic lipid and glucose metabolism in liver diseases","volume":"56","author":"Bechmann","year":"2012","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib183","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.cmet.2012.03.007","article-title":"The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling","volume":"15","author":"Fu","year":"2012","journal-title":"Cell. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib184","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00018-003-3216-3","article-title":"Peroxisome proliferator-activated receptor alpha target genes","volume":"61","author":"Mandard","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib185","first-page":"2010","article-title":"Peroxisome proliferator-activated receptor alpha target genes","author":"Rakhshandehroo","year":"2010","journal-title":"PPAR Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib186","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nrd4157","article-title":"Metabolic disorders: FGF21 analogue shows promise in the clinic","volume":"12","author":"Crunkhorn","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib187","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/ijo.2013.10","article-title":"Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation","volume":"37","author":"Straczkowski","year":"2013","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib188","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/ATVBAHA.113.301599","article-title":"Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors","volume":"33","author":"Chow","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib189","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","article-title":"The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes","volume":"18","author":"Gaich","year":"2013","journal-title":"Cell. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib190","article-title":"Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21","volume":"146","author":"Li","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib191","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1210\/en.2008-0816","article-title":"Fibroblast growth factor 21 corrects obesity in mice","volume":"149","author":"Coskun","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib192","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mce.2011.05.003","article-title":"The link between fibroblast growth factor 21 and sterol regulatory element binding protein 1c during lipogenesis in hepatocytes","volume":"342","author":"Zhang","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib193","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.bbadis.2011.01.003","article-title":"Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease","volume":"1812","author":"Gaemers","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib194","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2009.12.027","article-title":"The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight","volume":"211","author":"Dallinga-Thie","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib195","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1161\/ATVBAHA.114.304615","article-title":"Lipolysis, and not hepatic lipogenesis, is the primary modulator of triglyceride levels in streptozotocin-induced diabetic mice","volume":"35","author":"Willecke","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib196","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbalip.2014.03.013","article-title":"Physiological regulation of lipoprotein lipase","volume":"1841","author":"Kersten","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib197","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/meta.2001.19452","article-title":"Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins","volume":"50","author":"Marcoux","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib198","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0022-2275(20)31574-1","article-title":"Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia","volume":"42","author":"Campos","year":"2001","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib199","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.2337\/db09-0206","article-title":"ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan","volume":"58","author":"Hiukka","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib200","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00041433-200210000-00001","article-title":"Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis","volume":"13","author":"Proctor","year":"2002","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib201","article-title":"Remnant cholesterol, low-density lipoprotein cholesterol, and blood pressure as mediators from obesity to ischemic heart disease","author":"Varbo","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib202","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib203","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0009-8981(93)90062-9","article-title":"Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels","volume":"223","author":"Nakajima","year":"1993","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib204","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5551\/jat.E598","article-title":"Remnant lipoproteins as strong key particles to atherogenesis","volume":"16","author":"Fujioka","year":"2009","journal-title":"J.\u00a0Atheroscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib205","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0021-9150(00)00484-6","article-title":"Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study","volume":"154","author":"McNamara","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib206","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1161\/01.CIR.99.22.2858","article-title":"Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease","volume":"99","author":"Kugiyama","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib207","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"Varbo","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib208","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehs431","article-title":"Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction","volume":"34","author":"Jorgensen","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib209","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/CIRCULATIONAHA.113.003008","article-title":"Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation","volume":"128","author":"Varbo","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib210","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1373\/clinchem.2013.219881","article-title":"Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study","volume":"60","author":"Thomsen","year":"2014","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib211","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0140-6736(10)60545-4","article-title":"Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies","volume":"375","author":"Triglyceride Coronary Disease Genetics Collaboration","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib212","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib213","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ng.2795","article-title":"Common variants associated with plasma triglycerides and risk for coronary artery disease","volume":"45","author":"Do","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib214","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/138945009787846434","article-title":"Nonfasting hyperlipidemia and cardiovascular disease","volume":"10","author":"Nordestgaard","year":"2009","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib215","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1126\/science.106.2748.190","article-title":"Atherosclerosis and alimentary hyperlipemia","volume":"106","author":"Moreton","year":"1947","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib216","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.107.2780.371","article-title":"Physical state of lipids and foreign substances producing atherosclerosis","volume":"107","author":"Moreton","year":"1948","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib217","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1053\/meta.2002.33339","article-title":"Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration","volume":"51","author":"Chan","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib218","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2337\/diabetes.52.3.803","article-title":"Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome","volume":"52","author":"Watts","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib219","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0021-9150(99)00364-0","article-title":"Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease","volume":"150","author":"Mero","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib220","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.bbalip.2011.11.010","article-title":"Pathophysiology of hypertriglyceridemia","volume":"1821","author":"Hassing","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib221","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/dmr.5610030208","article-title":"Lipoprotein lipase in diabetes","volume":"3","author":"Taskinen","year":"1987","journal-title":"Diabetes Metab. Rev."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib222","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/MOL.0b013e328338cabc","article-title":"Recent insights into factors affecting remnant lipoprotein uptake","volume":"21","author":"Williams","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib223","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/hep.23916","article-title":"Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins","volume":"52","author":"Chen","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib224","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/hep.25580","article-title":"Inhibition of hepatic sulfatase-2 in\u00a0vivo: a novel strategy to correct diabetic dyslipidemia","volume":"55","author":"Hassing","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib225","doi-asserted-by":"crossref","first-page":"e79473","DOI":"10.1371\/journal.pone.0079473","article-title":"Genetic variation in SULF2 is associated with postprandial clearance of triglyceride-rich remnant particles and triglyceride levels in healthy subjects","volume":"8","author":"Matikainen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib226","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/oby.20682","article-title":"SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus","volume":"22","author":"Hassing","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib227","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1210\/jc.2013-2477","article-title":"Plasma apolipoprotein B-48 transport in obese men: a new tracer kinetic study in the postprandial state","volume":"99","author":"Wong","year":"2014","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib228","doi-asserted-by":"crossref","first-page":"E1427","DOI":"10.1210\/jc.2013-4037","article-title":"Effect of omega-3 fatty acid ethyl esters on apolipoprotein B-48 kinetics in obese subjects on a weight-loss diet: a new tracer kinetic study in the postprandial state","volume":"99","author":"Wong","year":"2014","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib229","doi-asserted-by":"crossref","first-page":"E1041","DOI":"10.1152\/ajpendo.00105.2013","article-title":"A\u00a0novel method for measuring intestinal and hepatic triacylglycerol kinetics","volume":"305","author":"Sun","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib230","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/sj.ijo.0800602","article-title":"Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity","volume":"22","author":"Riches","year":"1998","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib231","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1161\/01.ATV.0000032134.92180.41","article-title":"Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity","volume":"22","author":"Pont","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib232","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1172\/JCI110812","article-title":"Plasma low density lipoprotein transport kinetics in noninsulin-dependent diabetes mellitus","volume":"71","author":"Kissebah","year":"1983","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib233","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1262-3636(07)70213-6","article-title":"New insight into the pathophysiology of lipid abnormalities in type 2 diabetes","volume":"31","author":"Verges","year":"2005","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib234","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1007\/s00125-011-2444-6","article-title":"Clinical dyslipidaemia is associated with changes in the lipid composition and inflammatory properties of apolipoprotein-B-containing lipoproteins from women with type 2 diabetes","volume":"55","author":"Stahlman","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib235","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1042\/bst0311066","article-title":"Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein","volume":"31","author":"Packard","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib236","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/01.ATV.0000119681.47218.a4","article-title":"Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype","volume":"24","author":"Georgieva","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib237","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1161\/01.ATV.12.12.1496","article-title":"LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes","volume":"12","author":"Feingold","year":"1992","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib238","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1464-5491.1991.tb01652.x","article-title":"The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of type 2 diabetes","volume":"8","author":"Baynes","year":"1991","journal-title":"Diabet. Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib239","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2337\/diab.26.1.11","article-title":"Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism","volume":"26","author":"Nikkila","year":"1977","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib240","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/01.CIR.82.2.495","article-title":"Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk","volume":"82","author":"Austin","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib241","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.95.1.69","article-title":"Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study","volume":"95","author":"Lamarche","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib242","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/jama.1996.03540110029028","article-title":"Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women","volume":"276","author":"Gardner","year":"1996","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib243","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1161\/01.CIR.0000057982.50167.6E","article-title":"Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS)","volume":"107","author":"Vakkilainen","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib244","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1210\/jc.2003-030636","article-title":"Clinical review 163: cardiovascular endocrinology: low-density lipoprotein size and cardiovascular disease: a reappraisal","volume":"88","author":"Sacks","year":"2003","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00041433-200402000-00005","article-title":"Associations of low density lipoprotein particle composition with atherogenicity","volume":"15","author":"Lada","year":"2004","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib246","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0009-9120(03)00078-X","article-title":"Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity","volume":"36","author":"Rashid","year":"2003","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib247","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.bbalip.2013.07.009","article-title":"Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: Impact on small HDL particles","volume":"1831","author":"Stahlman","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.01.039_bib248","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/joim.12071","article-title":"Ectopic lipid storage and insulin resistance: a harmful relationship","volume":"274","author":"Bor\u00e9n","year":"2013","journal-title":"J Intern Med."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib249","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.mol.0000226115.97436.c0","article-title":"Diabetic dyslipidaemia","volume":"17","author":"Adiels","year":"2006","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2015.01.039_bib250","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nrcardio.2013.140","article-title":"Demystifying the management of hypertriglyceridaemia","volume":"10","author":"Watts","year":"2013","journal-title":"Nat. Rev. Cardiol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501500088X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501500088X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:23:36Z","timestamp":1762187016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191501500088X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":250,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S002191501500088X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.01.039","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New insights into the pathophysiology of dyslipidemia in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.01.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}